HIV SeropositivityHIV SeroprevalenceHIV InfectionsSubstance Abuse, IntravenousSexual BehaviorRisk FactorsSeroepidemiologic StudiesAntibodies, ViralAntibodies, BacterialChlamydophila pneumoniaeCross-Sectional StudiesImmunoglobulin GChlamydophila InfectionsSerologic TestsEnzyme-Linked Immunosorbent AssayHIV SeronegativityQuestionnairesPrevalenceCohort StudiesHelicobacter pyloriHelicobacter InfectionsProspective StudiesCase-Control StudiesAge FactorsToxocariasisAntibodies, ProtozoanRural PopulationUnited StatesCytomegalovirus InfectionsAcquired Immunodeficiency SyndromeOdds RatioAIDS SerodiagnosisHIV-1Logistic ModelsToxoplasmosisHerpesvirus 2, HumanRisk-TakingFollow-Up StudiesToxocaraBlood DonorsHepatitis CIncidenceLongitudinal StudiesBrazilHomosexuality, MalePapillomavirus InfectionsSexual PartnersTime FactorsSex FactorsHealth Knowledge, Attitudes, PracticeMultivariate AnalysisNeosporaSyphilisUrban PopulationHerpes GenitalisHomosexualityCytomegalovirusImmunoglobulin AAnti-HIV AgentsToxoplasmaCD4 Lymphocyte CountHuman papillomavirus 16Zimbabwe